Clinical Trial Translation Services

Regulatory-grade translation of informed consent forms, protocols, investigator brochures, and site documents — with back-translation and reconciliation when your IRB or sponsor requires it.

5.0 average rating on Google reviewsQuotes returned same business day

Scientist in gloves examining test tubes in a research laboratoryCertifiedGSA Schedule Holder
Billions
words translated
5,000+
vetted linguists
300+
languages
102,000+
projects delivered
  • HIPAA-trained staff
  • 300+ languages - 24/7 support
  • GSA Schedule Holder - NASPO ValuePoint Contract Holder - Trusted by State & Federal Agencies - Serving Major U.S. School Districts

What is clinical trial translation?

Clinical trial translation is the specialized translation of study documents — informed consent forms, protocols, investigator brochures, patient diaries, and site materials — by linguists experienced in clinical research. ICH E6 Good Clinical Practice requires consent information to be understandable to the trial subject, so patient-facing documents often add back-translation and reconciliation as an independent check.

A translation error in a trial isn't a typo — it's a finding

A mistranslated informed consent form can compromise the validity of consent itself. A drifted term across protocol versions can put data integrity in question. IRB submissions get delayed, sites get queried, and the sponsor answers for it. Trial documents need linguists who know clinical research and a process regulators recognize.

Research teams have trusted Taika since 2009

Taika Translations translates clinical trial documentation for sponsors, CROs, and research sites — 102,000+ projects delivered across 300+ languages, drawing on a network of 5,000+ vetted linguists, with a 5.0★ Google rating and staff trained on confidentiality. Back-translation and reconciliation are built into the workflow whenever your protocol requires them.

How trial translation projects run

  1. Share your document set and language list

    Request a quote with your documents, target countries and languages, timeline, and whether back-translation is required. Quotes are answered the same business day, with an NDA first if you require one.

  2. Clinical-experienced translation + TEP

    A linguist experienced in clinical research translates; a second qualified linguist independently edits and proofreads against the source — terminology consistent across every version and language.

  3. Back-translation and reconciliation where required

    For ICFs, ePRO/eCOA instruments, and patient diaries, an independent back-translation is compared against the original and discrepancies are reconciled — the documentation trail IRBs and sponsors ask for.

What you get

  • Clinical research linguists

    Translators experienced in trial content — consent language, protocol terminology, patient-reported outcomes — not a general pool.

  • Back-translation and reconciliation

    The independent-review step IRBs, ethics committees, and sponsors most often require for patient-facing documents.

  • TEP on every document

    Translation, independent editing, and second-linguist proofreading run on every deliverable, from ICF to CSR.

  • Multi-country programs, one vendor

    300+ languages coordinated as a single program with consistent terminology across every target country.

  • Confidential by structure

    Staff trained on confidentiality, secure file transfer, and an NDA signed whenever the sponsor or site requires one.

  • Timelines that respect IRB calendars

    Quotes answered the same business day, with firm timelines scoped to submission and site-activation deadlines.

Clinical trial documents carry regulatory and ethical weight that a general translation cannot meet. A mistranslated informed consent form, protocol amendment, or patient diary can delay an IRB submission, compromise consent, or put the integrity of the data itself in question.

Taika Translations translates the full document set a trial runs on — informed consent forms (ICF), protocols and amendments, investigator brochures (IB), patient diaries and ePRO/eCOA instruments, clinical study reports (CSR), site and recruitment materials, and IRB submissions — with translators experienced in clinical research subject matter and staff trained on confidentiality.

Built around what regulators expect

ICH E6 Good Clinical Practice (section 4.8 in E6(R2), carried into the informed-consent provisions of E6(R3)) requires informed consent information to be in a language understandable to the subject. For the documents where that standard is highest — consent forms, patient-facing instruments — Taika offers back-translation and reconciliation, the independent-review step IRBs, ethics committees, and sponsors most often ask for.

The ICH E6(R3) Good Clinical Practice guideline (which reached ICH Step 4 in January 2025) sharpens the field’s focus on participant-centricity, quality-by-design, robust data governance, and proportionate oversight. Translation that keeps consent and patient materials genuinely understandable — not just linguistically correct — is part of meeting that bar.

What you can order

  • Informed consent forms and assents — with back-translation and reconciliation on request.
  • Protocols, amendments, and investigator brochures — consistent terminology across every version.
  • Patient diaries, ePRO/eCOA, and recruitment materials — patient-facing language reviewed for readability.
  • Clinical study reports and regulatory submissions — for multi-country filings.

Clinical trial translation requirements: where they actually come from

Sponsors searching for “translation requirements for clinical trials” usually expect one rule. There isn’t one; the obligation comes from the consent and submission rules, and it lands on the sponsor and the IRB:

  • ICH E6 Good Clinical Practice — consent information must be in a language the participant understands.
  • FDA, 21 CFR 50.20 — for FDA-regulated studies, the information given to the subject must be in language understandable to the subject or their legally authorized representative. FDA’s consent rules also allow a short-form written consent presented orally under 21 CFR 50.27(b)(2), which brings its own witness requirements.
  • EU Clinical Trials Regulation (EU) No 536/2014 — participant information must be comprehensible to a layperson, and the language of each part of the application dossier is set by the Member State concerned. A multi-country EU trial therefore needs a language plan per country, not one translation per language.

What that means in practice: each translated consent version is reviewed and approved before use, the version number ties back to the approved source, and there is a documented record of who translated, who reviewed, and how discrepancies were resolved. That record is what Taika delivers alongside the translation.

ICF translation: the document reviewers look at hardest

Informed consent form (ICF) translation is where most trial translation problems surface, because it is the one document a participant actually signs. Taika’s ICF workflow:

  1. Starts from the approved source version and carries its version number and date into every translation.
  2. Translates for the reader, not the sentence — consent language is written for a lay participant, and a literal translation of a dense English ICF can come out harder to read than the original.
  3. Uses an independent back-translator where back-translation is required. A back-translation by the same linguist who did the forward translation is not an independent check.
  4. Reconciles and documents each discrepancy the back-translation surfaces, so the IRB or ethics committee can see what was changed and why.
  5. Re-translates against the new approved version when the protocol or consent is amended, rather than patching the old translation at site level.

Mistakes that get trial translations sent back

  • Translating a draft that later changes. The translated ICF then no longer matches the approved English version and has to be redone.
  • Terminology drift across amendments. The same endpoint, procedure or adverse-event term rendered three different ways across protocol versions invites queries.
  • Wrong regional variant. Spanish for participants in the United States is not automatically the same deliverable as Spanish for a site in Spain; the same is true for French, Portuguese and Chinese.
  • Licensed instruments translated ad hoc. Many patient-reported outcome questionnaires are copyrighted, and the instrument owner controls how translations are produced and validated, typically following ISPOR’s good-practice principles for translation and cultural adaptation. Check the licence before commissioning a translation.
  • Dates, units and numbers left in source format. Dosing, lab values and visit windows must read unambiguously in the target locale.

Clinical study report and protocol translation

Beyond patient-facing material, Taika translates the sponsor-side documents a submission runs on: clinical study protocols and amendments, investigator brochures, clinical study reports (structured to ICH E3), case report forms, and the regulatory correspondence around them. Terminology is held in a program glossary so the protocol, the CRF and the CSR use the same words for the same things in every language.

Machine translation and clinical trial documentation

Teams localizing trial documentation for both EU and FDA review often ask what quality threshold to set for machine translation before human review. No regulator publishes one, so any use of machine translation is a risk decision the sponsor owns and should document. Taika translates clinical trial documents with qualified human linguists and an independent second-linguist edit, with back-translation and reconciliation for participant-facing documents where required — so the question of a machine-translation threshold does not arise on work we deliver.

What to decide before you request a quote

  • Which documents, and which approved versions of each.
  • Which countries and languages, including regional variants.
  • Whether back-translation and reconciliation are required, and for which documents.
  • Whether you need a certificate of accuracy per document and language.
  • The file formats you need back — clean, tracked, or both.
  • Your IRB submission or site-activation date.

Request a quote with your document set, target languages, and whether back-translation is required, and Taika will scope the workflow to your protocol. For the regulatory background in more depth, read our guide to clinical trial translation and ICH-GCP requirements.

Start your clinical trial quote →
  • HIPAA-Trained Staff
  • 5.0★ Google Rating
  • Trusted by State & Federal Agencies

What we cover

  • Informed consent forms (ICF) and assents
  • Protocols and protocol amendments
  • Investigator brochures (IB)
  • Patient diaries and ePRO/eCOA instruments
  • Clinical study reports (CSR)
  • Site and recruitment materials
  • IRB and ethics committee submissions

Quality & confidentiality

  1. Translation by a linguist experienced in clinical research, with program-level terminology maintained across versions
  2. Independent edit and proofread by a second qualified linguist — verified against the source
  3. Back-translation and reconciliation on request for patient-facing documents; NDA available throughout

What clients say

  • “Impeccable expertise and a flawless manner of doing business, all topped with a heartwarming attitude.”

    Sergey P. · client since 2019

  • “Excellent 24/7 communication and engagement. Couldn't be happier about the cooperation.”

    Fazil · project client

Credentials & registrations

  • HIPAA-Trained Staff
  • GSA Schedule Holder
  • NASPO ValuePoint
  • Veteran-Owned (VOSB)
  • SAM.gov Registered
  • Meets ISO 17100 · 9001 · 27001
  • ATA-Certified Translators
  • 5.0★ Google Rating

Frequently Asked Questions

Why does informed consent translation matter so much in clinical trials?

ICH E6 Good Clinical Practice (section 4.8 in E6(R2); the informed-consent provisions of E6(R3)) requires that the informed consent form and related information be in a language understandable to the trial subject. A consent document a participant cannot fully read undermines both ethics review and the validity of the consent, so informed consent forms are translated with particular care and, where required, back-translated and reconciled.

What is back-translation, and when do you use it?

Back-translation is an independent translation of the target text back into the source language, compared against the original to surface meaning discrepancies. It is commonly requested by IRBs, ethics committees, and sponsors for informed consent forms, patient-reported outcome instruments (ePRO/eCOA), and patient diaries. Tell us if your protocol requires it and we build reconciliation into the workflow.

Can you handle a multi-country trial across many languages at once?

Yes. Taika coordinates multi-language trial translation with consistent terminology across all target languages, managed as a single program. Request a quote with your country and language list, document set, and timeline.

Who translates clinical trial documents — are they qualified?

Projects are assigned to professional linguists experienced in clinical research content, and every translation is independently edited and proofread by a second qualified linguist. We use ATA Certified translators whenever the client or content requires or requests it.

How is confidentiality handled for unpublished study data?

Protocols, investigator brochures, and study reports move through secure transfer and are handled only by the assigned team, with staff trained on confidentiality. Taika signs a non-disclosure agreement whenever the sponsor, CRO, or site requires one.

How quickly can trial documents be translated?

Quotes are answered the same business day and include a firm timeline scoped to your document set and language list. Tell us your IRB submission or site-activation deadline and Taika will confirm the schedule — including the extra time back-translation and reconciliation add — before you commit.

What are the translation requirements for clinical trials?

There is no single translation regulation; the requirement comes from the consent rules. ICH E6 Good Clinical Practice requires consent information in a language the participant understands. For FDA-regulated studies, 21 CFR 50.20 requires consent information to be in language understandable to the subject. In the EU, the Clinical Trials Regulation (EU) No 536/2014 requires participant information to be comprehensible to a layperson and leaves the language of each document to the Member State concerned. In practice that means every translated consent version is reviewed and approved by the IRB or ethics committee before use, and the sponsor keeps a documented translation and review trail.

What does ICF translation involve beyond translating the text?

Informed consent form (ICF) translation starts from the IRB-approved source version, keeps the version number and date tied to that source, translates for the participant's reading level rather than word for word, and — where the IRB, ethics committee or sponsor requires it — adds an independent back-translation and a reconciliation report. When the protocol or consent is amended, the translated ICF is updated against the new approved version, not edited by hand at the site.

Do you translate clinical study reports and case report forms?

Yes. Clinical study reports (CSRs), which follow the ICH E3 structure, and case report forms (CRFs) are translated by linguists experienced in clinical research, with tables, units, and terminology kept consistent with the protocol and the rest of the submission. Tell us whether you need a full CSR, a synopsis only, or selected sections, and which regulator the translation is for.

Can machine translation be used for clinical trial documents?

No regulator publishes a numeric quality threshold for machine translation of trial documents, so any use of it is a risk decision the sponsor owns and should document. Taika translates clinical trial documents with qualified human linguists and an independent second-linguist edit, and adds back-translation and reconciliation for participant-facing documents where required. If your team is weighing machine translation for part of a trial package, tell us which documents and we will explain how we would handle each one before you commit.

Can you provide a certificate of accuracy for translated trial documents?

Yes. Translated trial documents can be delivered with a signed certificate of accuracy for each document and language, which sponsors, CROs, IRBs and ethics committees frequently ask for as part of the submission record. Say in your quote request whether you need one and how it should be formatted.

What should I send to get an accurate clinical trial translation quote?

Send the approved source documents (or current drafts with version numbers), the target countries and languages — including the regional variant, such as Spanish for U.S. participants versus Spanish for Spain — whether back-translation and reconciliation are required, whether you need a certificate of accuracy, the file format you need back (clean, tracked, or both), and your IRB submission or site-activation date.

Ready when you are

Prefer to talk? Call+1 830-355-2205or +1 865-258-7903, quotes returned same business day.

Reviewed by Margarita Ehlinger, Chief Project Manager — updated